Almost a virus – how AAV powers modern gene therapy
About this episode
The episode discusses the engineering and manufacturing of viral vectors for gene therapy with Dr. Dan Mitchell.
In this episode, the hosts sit down with Dr. Dan Mitchell of Matica Biotechnology to explore how viral vectors are engineered, analyzed, and manufactured for cell and gene therapy. The conversation spans CDMO workflows, AAV biology, and the critical role of qPCR and digital PCR in ensuring safety, quality, and performance.
People in this episode
Guest: Dr. Dan Mitchell
Topics covered
- gene therapy
- viral vectors
- AAV biology
- CDMO workflows
- qPCR
- digital PCR
More episodes of Absolute Gene-ius
- Multiplexing in action – from simplicity to scientific complexity
- Science happens, and so do mistakes
- How sequencing and PCR work together in oncology research
- When PCR gets dirty - tackling PCR inhibitors
- Tracking grape pathogens from air to vine
- Season 4 – new voices, new discoveries
Explore listener stats, chart rankings, contacts and more on the Absolute Gene-ius podcast page.